Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time-Reference-Cited by-同舟云学术

Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time

Published:2022-01 Issue:4 Volume:11 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin & Trans Imm

Author:

Havervall Sebastian¹^ORCID,Marking Ulrika¹,Greilert‐Norin Nina¹,Gordon Max¹,Ng Henry¹²,Christ Wanda³,Phillipson Mia²,Nilsson Peter⁴^ORCID,Hober Sophia⁴^ORCID,Blom Kim¹,Klingström Jonas³^ORCID,Mangsbo Sara⁵,Åberg Mikael⁶,Thålin Charlotte¹

Affiliation:

1. Department of Clinical Sciences Karolinska Institutet Danderyd Hospital Stockholm Sweden

2. Department of Medical Cell Biology SciLifeLab Uppsala University Uppsala Sweden

3. Department of Medicine Huddinge Center for Infectious Medicine Karolinska Institutet Stockholm Sweden

4. Department of Protein Science SciLifeLab KTH Royal Institute of Technology Stockholm Sweden

5. Department of Pharmacy SciLifeLab Uppsala University Uppsala Sweden

6. Department of Medical Sciences Clinical Chemistry SciLifeLab Uppsala University Uppsala Sweden

Funder

Center for Innovative Medicine

Familjen Erling-Perssons Stiftelse

Science for Life Laboratory

Vetenskapsrådet

Knut och Alice Wallenbergs Stiftelse

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1388

Reference42 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

2. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

4. Waning Immunity after the BNT162b2 Vaccine in Israel

5. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera;Vaccines;2024-08-13

2. Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes;Viruses;2024-04-26

3. Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum;Frontiers in Immunology;2024-03-15

4. Longitudinal antibody dynamics after COVID-19 vaccine boosters based on prior infection status and booster doses;Scientific Reports;2024-02-25

5. Antibody Response to Sars-CoV-2 in Adults After 18 Months of Second Dose Vaccination of Astra Zeneca;BIO Web of Conferences;2024